Literature DB >> 16963005

Role of KATP channels in sepsis.

James F Buckley1, Mervyn Singer, Lucie H Clapp.   

Abstract

Sepsis is an infection-induced inflammatory syndrome responsible for approximately 10% of all deaths worldwide. While pathophysiological mechanisms remain to be fully unravelled, new insights and discoveries are yielding significant improvements in outcome, particularly in the high mortality conditions of shock and multi-organ failure. One potential target is the ATP-sensitive potassium (K(ATP)) channel, an ion channel critical to the cardiovascular stress response. Excessive activation of the vascular channel is now recognised as a major cause of hypotension and vascular hyporesponsiveness to catecholamines in septic shock. Some researchers advocate therapeutic blockade of these channels; however, outside the vasculature, channel opening may actually represent a protective mechanism against cellular damage. In this review we critically examine the role of the K(ATP) channel in sepsis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16963005     DOI: 10.1016/j.cardiores.2006.07.011

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  35 in total

Review 1.  Ion channels in inflammation.

Authors:  Michael Eisenhut; Helen Wallace
Journal:  Pflugers Arch       Date:  2011-01-29       Impact factor: 3.657

Review 2.  Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.

Authors:  Nathan R Tykocki; Erika M Boerman; William F Jackson
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

3.  Vascular KATP channels protect from cardiac dysfunction and preserve cardiac metabolism during endotoxemia.

Authors:  Qadeer Aziz; Jianmin Chen; Amie J Moyes; Yiwen Li; Naomi A Anderson; Richard Ang; Dunja Aksentijevic; Sonia Sebastian; Adrian J Hobbs; Christoph Thiemermann; Andrew Tinker
Journal:  J Mol Med (Berl)       Date:  2020-07-06       Impact factor: 4.599

Review 4.  The host response to sepsis and developmental impact.

Authors:  James Wynn; Timothy T Cornell; Hector R Wong; Thomas P Shanley; Derek S Wheeler
Journal:  Pediatrics       Date:  2010-04-26       Impact factor: 7.124

5.  Vascular ATP-sensitive potassium channels are over-expressed and partially regulated by nitric oxide in experimental septic shock.

Authors:  Solène Collin; Nacira Sennoun; Anne-Gaëlle Dron; Mathilde de la Bourdonnaye; Chantal Montemont; Pierre Asfar; Patrick Lacolley; Ferhat Meziani; Bruno Levy
Journal:  Intensive Care Med       Date:  2011-03-03       Impact factor: 17.440

Review 6.  Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside.

Authors:  B Levy; S Collin; N Sennoun; N Ducrocq; A Kimmoun; P Asfar; P Perez; F Meziani
Journal:  Intensive Care Med       Date:  2010-09-23       Impact factor: 17.440

7.  Comparative effects of recombinant human activated protein C and dexamethasone in experimental septic shock.

Authors:  Youcef Bouazza; Nacira Sennoun; Charlène Strub; Véronique Regnault; Sebastien Gibot; Ferhat Meziani; Patrick Lacolley; Bruno Levy
Journal:  Intensive Care Med       Date:  2011-08-18       Impact factor: 17.440

8.  Kir6.2 knockout aggravates lipopolysaccharide-induced mouse liver injury via enhancing NLRP3 inflammasome activation.

Authors:  Ren-Hong Du; Jun Tan; Nan Yan; Ling Wang; Chen Qiao; Jian-Hua Ding; Ming Lu; Gang Hu
Journal:  J Gastroenterol       Date:  2013-06-16       Impact factor: 7.527

9.  Ca2+/calcineurin regulation of cloned vascular K ATP channels: crosstalk with the protein kinase A pathway.

Authors:  N N Orie; A M Thomas; B A Perrino; A Tinker; L H Clapp
Journal:  Br J Pharmacol       Date:  2009-05-07       Impact factor: 8.739

10.  Hyperkalemia accompanies hemorrhagic shock and correlates with mortality.

Authors:  Joel Avancini Rocha Filho; Ricardo Souza Nani; Luiz Augusto Carneiro D'Albuquerque; Carla Augusto Holms; João Plínio Souza Rocha; Luís Marcelo Sá Malbouisson; Marcel Cerqueira César Machado; Maria José Carvalho Carmona; José Otávio Costa Auler Júnior
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.